These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6841013)

  • 1. Reversal of galactose cataract with Sorbinil in rats.
    Hu TS; Datiles M; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1983 May; 24(5):640-4. PubMed ID: 6841013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and reversal of galactose cataract in rats with topical Sorbinil.
    Hu TS; Merola LO; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1984 May; 25(5):603-5. PubMed ID: 6715136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Varagiannis E
    Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract.
    Beyer-Mears A; Kelly K; Cruz E
    Pharmacology; 1985; 31(3):170-9. PubMed ID: 3931105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S; Mori K; Wyman M; Kador PF
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of sugar cataract in the dog.
    Sato S; Takahashi Y; Wyman M; Kador PF
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG; Laver NM; Jacot JL; Glover JP
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
    Datiles MB; Kador PF; Kashima K; Kinoshita JH; Sinha A
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataract formation through the polyol pathway is associated with free radical production.
    Kubo E; Miyoshi N; Fukuda M; Akagi Y
    Exp Eye Res; 1999 Apr; 68(4):457-64. PubMed ID: 10192803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural cytochemistry: effect of Sorbinil on arylsulfatases in cataractous lenses.
    Harries W; Tsui J; Unakar NJ
    Curr Eye Res; 1985 Jun; 4(6):657-66. PubMed ID: 4028788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of in utero galactose-induced cataract development by an aldose reductase inhibitor in rat--electron microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1993; 37(2):192-8. PubMed ID: 8230845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil.
    Frank RN; Keirn RJ; Kennedy A; Frank KW
    Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1519-24. PubMed ID: 6642931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aldose reductase inhibitors on lenticular dulcitol level in galactose fed rats.
    Unakar NJ; Tsui JY; Johnson MJ
    J Ocul Pharmacol; 1992; 8(3):199-212. PubMed ID: 1453083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase inhibitors and galactose toxicity in neonatal and maternal rat lenses.
    Unakar NJ; Tsui J; Anthony P; Johnson M
    J Ocul Pharmacol; 1993; 9(4):341-53. PubMed ID: 8106840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid phosphatase II. Cytochemical localization in lenses of normal and galactose-fed rats.
    Unakar NJ; Harries W; Tsui J
    Exp Eye Res; 1985 Jan; 40(1):117-26. PubMed ID: 3920063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased ocular blood flow and 125I-albumin permeation in galactose-fed rats: inhibition by sorbinil.
    Tilton RG; Chang K; Weigel C; Eades D; Sherman WR; Kilo C; Williamson JR
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):861-8. PubMed ID: 3372163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.